HR Execs on the Move


 
M2GEN is an oncology-focused bioinformatics solutions company advancing precision medicine and transforming cancer care through clinical and molecular data and analytics tools. The company`s innovative dataset accelerates the discovery, development, and delivery of personalized therapies. M2GEN`s Oncology Research Information Exchange Network® (ORIEN), an alliance of NCI-Designated cancer centers that gather de-identified and lifetime-consented clinical and genomic patient data for research purposes, enables a collaborative approach to the fight against cancer for patients today and tomorrow. M2GEN currently has more than 300,000 total consented patients across a network of 18 cancer centers in 10 states.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.m2gen.com
  • P.O. Box 5519
    Hudson, FL USA 34667
  • Phone: 813.384.5624

Executives

Name Title Contact Details
Kyle Dunn
Chief Revenue Officer Profile
Joseph Smith
Senior Vice President and Chief Financial Officer Profile
Eric Anderson
Chief Financial Officer Profile
May Yoon
Chief People Officer Profile

Jobs

Chief Information Security Officer

M2Gen Remote
M2Gen is seeking a strong CISO to establish, develop, and grow our information security and privacy practice. Working closely with the CTO, executive leadership, and the broader organization, the ideal candidate brings in-depth knowledge of security focused software construction, security and privacy policy development and practice, solid understanding of ...

Similar Companies

Crescendo Bioscience

Crescendo Bioscience is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bioneer

Bioneer is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SimBioSys Inc

SimBioSys Inc is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

B-Bridge International

B-Bridge International is a Cupertino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Generex

Generex Biotechnology has been engaged primarily in the research and development of drug delivery systems and technologies. Our primary focus has been our proprietary technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a handheld aerosol applicator. Generex Biotechnology has a two business focuses: 1) implementing an acquisition strategy and 2) financing sponsored clinical trials. We are positioning ourselves as a diversified holding company involved in increasing our "pipeline" of compounds, therapies, treatments, diagnostics, and technologies in all stages in the FDA process through accretive acquisitions. We are also strategically aligning ourselves with the global biopharmaceutical companies by providing a financing solution to them as sponsors of clinical trials, which are conducted by patient care providers (PCPs) such as hospitals, medical research institutes, centers, and clinics.